[1]孙继高,唐开强,郑泽陆,等.骨质疏松高风险人群中医辨识量表的测试优化研究[J].中医正骨,2023,35(09):37-43.
　SUN Jigao,TANG Kaiqiang,ZHENG Zelu,et al.A study of testing and optimization of the traditional Chinese medicine identification scale for high-risk population of osteoporosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2023,35(09):37-43.
点击复制

骨质疏松高风险人群中医辨识量表的测试优化研究()
分享到：

《中医正骨》[ISSN:1001-6015/CN:41-1162/R]

卷:
第35卷
期数:
2023年09期
页码:
37-43
栏目:
调查研究
出版日期:
2023-09-20

文章信息/Info

Title:
A study of testing and optimization of the traditional Chinese medicine identification scale for high-risk population of osteoporosis
作者:
孙继高1; 唐开强2; 郑泽陆2; 王荣田2; 何海军3; 奚向宇4; 陈卫衡2
1.北京中医药大学东方医院,北京 100078; 2.北京中医药大学第三附属医院,北京 100029; 3.中国中医科学院望京医院,北京 100102; 4.北京市西城区广外医院,北京 100055
Author(s):
SUN Jigao1; TANG Kaiqiang2; ZHENG Zelu2; WANG Rongtian2; HE Haijun3; XI Xiangyu4; CHEN Weiheng2
1.Dongfang Hospital,Beijing University of Chinese Medicine,Beijing 100078,China2.Beijing University of Chinese Medicine Third Affiliated Hospital,Beijing 100029,China3.Wangjing Hospital of CACMS,Beijing 100102,China4.Beijing Xicheng Guangwai Hospital,Beijing 100055,China
关键词:
骨质疏松;  辨识;  量表;  风险评估;  可行性;  信度;  效度
Keywords:
osteoporosis;  identification;  scale;  risk assessment;  feasibility;  reliability;  validity
摘要:
目的:对骨质疏松高风险人群中医辨识量表进行测试优化。方法:以2020年9月至2021年1月在北京中医药大学第三附属医院、中国中医科学院望京医院及北京市西城区广外医院门诊就诊的患者为调查对象,要求调查对象完成骨质疏松高风险人群中医辨识量表、国际骨质疏松基金会(International Osteoporosis Foundation,IOF)骨质疏松风险一分钟测试题、亚洲人骨质疏松症自我筛查工具(osteoporosis self-assessment tool for Asians,OSTA)量表、疼痛视觉模拟量表(visual analogue scale,VAS)、简明健康状况调查表(short form 36 health survey questionnaire,SF-36)及骨密度检测(包括腰椎和髋部)。评价骨质疏松高风险人群中医辨识量表的可行性、信度、效度及判别效果。结果:①可行性评价结果。共发放骨质疏松高风险人群中医辨识量表250份,回收236份,有效量表228份,回收率94.4%,有效率91.2%。调查对象完成骨质疏松高风险人群中医辨识量表的时间均≤5 min。所有调查对象均同时完成骨密度检测及其余4个量表,调查对象完成所有量表的时间均≤20 min。②信度评价结果。骨质疏松高风险人群中医辨识量表的克龙巴赫α系数为0.882、Spearman-Brown系数为0.891,其中针对前10个条目的克龙巴赫α系数为0.770。③结构效度评价结果。经探索性因子分析,骨质疏松高风险人群中医辨识量表的32个条目中,手足烦热和健忘2个条目的负荷值在所有因子上均<0.4,予以剔除。对剩余30个条目重新进行探索性因子分析,共提取出9个公因子,累积方差贡献率为61.215%。9个公因子分别代表下肢症状、头目症状、疼痛症状、睡眠情绪、头面体征、寒热症状、躯体体征、躯体症状、头面症状9个维度,对应的中医证候体现了骨质疏松症患者肾精亏虚、肾阳虚、肝肾阴虚、肝郁血虚、脾胃虚弱等病机特点,也与原发性骨质疏松症中医证型基本相符。对量表中前10个条目进行探索性因子分析,共提取出3个公因子,累积方差贡献率为61.200%。3个公因子分别代表躯体症状、疼痛及躯体体征3个维度。应用SPSS AMOS24软件对上述3因子分析模型进行验证性因子分析,结果显示模型拟合较好。④效标关联效度评价结果。骨质疏松高风险人群中医辨识量表前10个条目评分和量表总分(30个条目)与骨密度分类、腰椎骨密度、髋部骨密度及SF-36中8个方面得分均呈负相关(骨密度分类:r=-0.190,P=0.004; r=-0.231,P=0.000; 腰椎骨密度:r=-0.144,P=0.030; r=-0.198,P=0.003; 髋部骨密度:r=-0.218,P=0.001; r=-0.272,P=0.000; SF-36生理功能:r=-0.280,P=0.000; r=-0.330,P=0.000; SF-36生理职能:r=-0.324,P=0.000; r=-0.346,P=0.000; SF-36身体疼痛:r=-0.430,P=0.000; r=-0.434,P=0.000; SF-36总体健康:r=-0.460,P=0.000; r=-0.495,P=0.000; SF-36活力:r=-0.220,P=0.001; r=-0.292,P=0.000; SF-36社会功能:r=-0.282,P=0.000; r=-0.326,P=0.000; SF-36情感职能:r=-0.174,P=0.009; r=-0.259,P=0.000; SF-36精神健康:r=-0.251,P=0.000; r=-0.320,P=0.000),与OSTA指数、疼痛VAS评分均呈正相关(OSTA指数:r=0.153,P=0.021; r=0.140,P=0.035; 疼痛VAS评分:r=0.453,P=0.000; r=0.430,P=0.000); IOF骨质疏松风险一分钟测试结果与前10个条目评分不存在相关性(r=0.127,P=0.055),与量表总分(30个条目)呈正相关(r=0.168,P=0.011)。⑤判别效果。以骨密度诊断结果为金标准,基于骨质疏松高风险人群中医辨识量表前10个条目评分和量表总分(30个条目)判别骨量异常的受试者操作特征曲线下面积分别为0.636[95%CI(0.564,0.709)]和0.650[95%CI(0.579,0.721)],最佳截断值分别为2分和5分,即符合骨质疏松高风险人群中医辨识量表前10个条目中的2个及以上,或符合全部30个条目中的5个及以上,就可判定为骨量异常,为骨质疏松高风险人群。结论:骨质疏松高风险人群中医辨识量表具有较好的可行性和信度; 优化后的量表具有良好的效度,具备一定的判别骨量异常的能力,可用于骨质疏松高风险人群的筛查评估。
Abstract:
Objective:To test and optimize the traditional Chinese medicine(TCM)identification scale for high-risk population of osteoporosis(OP).Methods:Patients who were treated in Beijing University of Chinese Medicine Third Affiliated Hospital,Wangjing Hospital of CACMS and Beijing Xicheng Guangwai Hospital from September 2020 to January 2021 were selected as the subjects.The participants were asked to complete the TCM identification scale for high-risk population of OP,the International Osteoporosis Foundation(IOF)one-minute OP risk check,the osteoporosis self-assessment tool for Asians(OSTA)scale,the pain visual analogue scale(VAS),the short form 36 health survey questionnaire(SF-36)and bone mineral density(BMD)measurement(including lumbar spine and hip).The feasibility,reliability,validity and discriminative effects of the TCM identification scale for high-risk population of OP were evaluated.Results:①Results of feasibility evaluation.Two hundred and fifty TCM identification scale questionnaires for high-risk population of OP were handed out,and 236 ones returned,among which 228 ones were valid,with the response rate of 94.4% and the effective rate of 91.2%,and the time for participants to finish the scale did not exceed 5 minutes.All participants finished the BMD measurement and the other 4 scales synchronously,and the time for them to finish all scales was less than 20 minutes.②Results of reliability evaluation.The Cronbach's α coefficient of the TCM identification scale for high-risk population of OP was 0.882,and the Spearman-Brown coefficient was 0.891,with a Cronbach's α coefficient of 0.770 for the first 10 items.③Results of structural validity evaluation.As indicated by exploratory factor analysis,among the 32 items in the TCM identification scale for high-risk population of OP,2 items,i.e.,“vexing heat in the extremities”and“forgetfulness”,had factor loadings of<0.4 across all factors and were therefore excluded.An exploratory factor analysis was re-performed on the remaining 30 items,9 common factors were extracted,with a cumulative variance contribution rate of 61.215%.The 9 common factors represented 9 dimensions,including lower limb symptoms,head and eye symptoms,pain symptoms,sleep emotions,head-face signs,cold and heat symptoms,physical signs,physical symptoms,and head-face symptoms.These dimensions corresponded to the TCM syndromes of OP patients,including kidney-essence deficiency,kidney-yang deficiency,liver-kidney yin deficiency,liver-qi stagnation and blood deficiency,and spleen-stomach weakness,which were generally consistent with the TCM syndromes of primary OP.Another exploratory factor analysis was performed on the top 10 items of the scale,3 common factors were extracted with a cumulative variance contribution rate of 61.200%.These 3 common factors represented 3 dimensions,i.e.,physical symptoms,pain signs and physical signs.The models generated from the above 3 common factors analyses were further validated through confirmatory factor analysis using SPSS AMOS24 software,and the results indicated a good model fit.④Results of criterion-related validity evaluation.The scores of the top 10 items of the TCM identification scale for high-risk population of OP and the total score(30 items)were negatively correlated with BMD classification,lumbar spine BMD,hip BMD and scores of 8 aspects in SF-36(BMD classification:r=-0.190,P=0.004; r=-0.231,P=0.000; lumbar spine BMD:r=-0.144,P=0.030; r=-0.198,P=0.003; hip BMD:r=-0.218,P=0.001; r=-0.272,P=0.000; SF-36 physical function:r=-0.280,P=0.000; r=-0.330,P=0.000; SF-36 role-physical:r=-0.324,P=0.000; r=-0.346,P=0.000; SF-36 bodily pain:r=-0.430,P=0.000; r=-0.434,P=0.000; SF-36 general health:r=-0.460,P=0.000; r=-0.495,P=0.000; SF-36 vitality:r=-0.220,P=0.001; r=-0.292,P=0.000; SF-36 social function:r=-0.282,P=0.000; r=-0.326,P=0.000; SF-36 role-emotional:r=-0.174,P=0.009; r=-0.259,P=0.000; SF-36 mental health:r=-0.251,P=0.000; r=-0.320,P=0.000).The scores of the top 10 items of the TCM identification scale for high-risk population of OP and the total score(30 items)were positively correlated with the OSTA index and pain VAS score(OSTA index:r=0.153,P=0.021; r=0.140,P=0.035; pain VAS score:r=0.453,P=0.000; r=0.430,P=0.000).The results of IOF one-minute OP risk check were not correlated with the scores of the top 10 items(r=0.127,P=0.055),but were positively correlated with the total score(30 items)of the scale(r=0.168,P=0.011).⑤Discriminative effects.With BMD diagnosis results as the gold standard,based on the scores of the top 10 items and the total score(30 items)of the TCM identification scale for high-risk population of OP,the discriminative effects of the TCM identification scale for high-risk population of OP was evaluated by using the receiver operating characteristic(ROC)curve,and the areas under the curve(AUC)of participants with abnormal bone mass were 0.636(95%CI(0.564,0.709))and 0.650(95%CI(0.579,0.721))respectively,with the optimal cutoff values of 2 points and 5 points respectively,which suggested that participants who scored 2 points or more on the top 10 items or 5 points or more on all 30 items of the TCM identification scale could be identified as abnormal bone mass and considered as individuals at high risk of OP.Conclusion:TCM identification scale for high-risk population of OP has good feasibility and reliability.The optimized scale has good validity and a certain ability to discriminate abnormal bone mass,and can be used for screening and evaluation of high-risk population of OP.

参考文献/References:

[1] BIJLSMA A Y,MESKERS C G,WESTENDORP R G,et al.Chronology of age-related disease definitions:osteoporosis and sarcopenia[J].Ageing Res Rev,2012,11(2):320-324.
[2] 贺丽英,孙蕴,要文娟,等.2010—2016年中国老年人骨质疏松症患病率Meta分析[J].中国骨质疏松杂志,2016,22(12):1590-1596.
[3] SI L,WINZENBERG T M,JIANG Q,et al.Projection of osteoporosis-related fractures and costs in China:2010-2050[J].Osteoporos Int,2015,26(7):1929-1937.
[4] 中华医学会物理医学与康复学分会,中国老年学和老年医学学会骨质疏松康复分会.原发性骨质疏松症康复干预中国专家共识[J].中华物理医学与康复杂志,2019,41(1):1-7.
[5] 中华医学会骨质疏松和骨矿盐疾病分会.原发性骨质疏松症诊疗指南(2017)[J].中国骨质疏松杂志,2019,25(3):281-309.
[6] 田峰.基于广义偏线性模型的40-65岁女性原发性骨质疏松症筛检工具研究[D].北京:中国中医科学院,2011.
[7] 李浩月,荣爽,程静,等.不同骨质疏松风险评估工具的筛检效果评价[J].中国骨质疏松杂志,2019,25(9):1307-1311.
[8] 魏戌,章轶立,谢雁鸣.原发性骨质疏松症中医药防治策略与研究方法[J].中国中医药信息杂志,2018,25(1):5-9.
[9] 孙继高,傅繁誉,王荣田,等.基于德尔菲法的骨质疏松高风险人群中医症状辨识研究[J].中国中医基础医学杂志,2021,27(5):792-795.
[10] 张瑛,杨圆圆,罗艳虹,等.肝硬化患者报告临床结局量表计量心理学特征考核[J].中国卫生统计,2016,33(3):400-403.
[11] 沈秋明,沈恬,王泽洲,等.骨质疏松患者自我管理行为量表的效度和信度评价[J].中华全科医学,2018,16(9):1409-1413.
[12] 李灿,辛玲.调查问卷的信度与效度的评价方法研究[J].中国卫生统计,2008,25(5):541-544.
[13] BERGLUND A L,ERICSSON K.Different meanings of quality of life:a comparison between what elderly persons and geriatric staff believe is of importance[J].Int J Nurs Pract,2003,9(2):112-119.
[14] 王泽洲,沈秋明,施悦,等.骨质疏松症自我效能量表在上海社区居民的效度与信度分析[J].中国骨质疏松杂志,2018,24(9):1225-1228.
[15] 吴明隆.问卷统计分析实务:SPSS操作与应用[M].重庆:重庆大学出版社,2019.
[16] 葛继荣,王和鸣,郑洪新,等.中医药防治原发性骨质疏松症专家共识(2020)[J].中国骨质疏松杂志,2020,26(12):1717-1725.
[17] 施悦,王泽洲,沈秋明,等.社区医护人员骨质疏松症防控行为量表的效度和信度分析[J].上海交通大学学报(医学版),2018,38(4):439-444.
[18] MCDONALD R P,HO M H.Principles and practice in reporting structural equation analyses[J].Psychol Methods,2002,7(1):64-82.
[19] International Osteoporosis FoundatioN.IOF one-minute osteoporosis risk test[EB/OL].[2022-06-15].https://riskcheck.osteoporosis.foundation.
[20] NAYAK S,EDWARDS D L,SALEH A A,et al.Systematic review and meta-analysis of the performance of clinical risk assessment instruments for screening for osteoporosis or low bone density[J].Osteoporos Int,2015,26(5):1543-1554.
[21] 全婷,杨定焯,张菊英,等.四川省50岁及以上妇女骨质疏松筛检工具的建立及评价[J].现代预防医学,2009,36(6):1058-1060.
[22] 林吉生.老年男性原发性骨质疏松症患病率调查及筛检工具的建立[D].北京:首都医科大学,2016.
[23] 张菊英,吴涛,杨定焯,等.中国大陆地区妇女骨质疏松筛选工具探讨[J].中国修复重建外科杂志,2007,21(1):86-89.
[24] 黄琪仁,章振林,周琦,等.上海市绝经后妇女低骨量的简易筛选方法的建立和验证[J].中华医学杂志,2007,87(12):808-811.
[25] HUANG J Y,SONG W Z,HUANG M.Effectiveness of osteoporosis self-assessment tool for Asians in screening for osteoporosis in healthy males over 40 years old in China[J].J Clin Densitom,2017,20(2):153-159.
[26] 李超,费琦,杨鹤,等.OSTA/OST筛选工具在男性骨质疏松症中的应用进展[J].临床和实验医学杂志,2012,11(24):1990-1992.
[27] SUBRAMANIAM S,CHAN C Y,SOELAIMAN I N,et al.The performance of osteoporosis self-assessment tool for Asians(OSTA)in identifying the risk of osteoporosis among Malaysian population aged 40 years and above[J].Arch Osteoporos,2019,14(1):117.
[28] 孙继高.基于德尔菲法骨质疏松高风险人群中医证候辨识工具构建及应用研究[D].北京:中国中医科学院,2021.

相似文献/References:

[1]李林军.应用膨胀式椎弓根螺钉内固定治疗合并骨质疏松的 胸腰椎退行性疾病[J].中医正骨,2015,27(08):49.
[2]韩艳,温利平,刘娜,等.补肾活血方对去卵巢大鼠骨代谢及骨密度的影响[J].中医正骨,2015,27(12):7.
　HAN Yan,WEN Liping,LIU Na,et al.Effect of Bushen Huoxue Fang(补肾活血方)on bone metabolism and bone mineral density in the ovariectomized rats[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(09):7.
[3]李学朋,朱立国.骨疏康胶囊对去卵巢大鼠骨小梁的影响[J].中医正骨,2015,27(12):12.
　LI Xuepeng,ZHU Liguo.Effect of Gushukang Jiaonang(骨疏康胶囊)on bone trabecula in the ovariectomized rats[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(09):12.
[4]陈冠军,陈扬,庄汝杰.可灌注骨水泥椎弓根螺钉系统 在老年腰椎疾患手术中的应用[J].中医正骨,2015,27(02):40.
[5]王丹辉,贲越,韩梅.林蛙油治疗绝经后骨质疏松症的临床研究[J].中医正骨,2014,26(01):27.
　Wang Danhui*,Ben Yue,Han Mei..Clinical study of Rana temporaria oil in the treatment of postmenopausal osteoporosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2014,26(09):27.
[6]黄建华,黄建武,李慧辉,等.加味左归丸对绝经后骨质疏松症肝肾不足证 患者骨密度的影响[J].中医正骨,2013,25(11):19.
　Huang Jianhua*,Huang Jianwu,Li Huihui,et al.Effect of JIAWEI ZUOGUI pill on bone mineral density in postmenopausal osteoporosis patients with deficiency of liver and kidney[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2013,25(09):19.
[7]项旻,杨虹,林爱菊,等.绝经后2型糖尿病患者骨质疏松与血微量元素的关系研究[J].中医正骨,2013,25(12):20.
　Xiang Min*,Yang Hong,Lin Aiju,et al.Clinical study on the relationship between osteoporosis and serum trace elements levels in postmenopausal women with type 2 diabetes[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2013,25(09):20.
[8]史晓林,李春雯,张志强.弱阳离子磁珠分离技术和基质辅助激光解吸电离飞行时间质谱技术在原发性Ⅰ型骨质疏松症血清标志蛋白筛选中的应用[J].中医正骨,2014,26(03):5.
　Shi Xiaolin*,Li Chunwen,Zhang Zhiqiang..Application of magnetic beads based weak cation exchange separation technology and matrix-assisted laser desorption-ionization time of flight mass spectrometry technology in screening serum protein markers of primary type-Ⅰ osteoporosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2014,26(09):5.
[9]李明,徐明雄,冯左基,等.自拟壮骨方治疗绝经后骨质疏松症的疗效及作用机制研究[J].中医正骨,2014,26(09):21.
　Li Ming*,Xu Mingxiong,Feng Zuoji,et al.Study on the curative effect and mechanism of action of self-made ZHUANGGU decoction in treatment of postmenopausal osteoporosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2014,26(09):21.
[10]陈俊杰,李晴晴,夏瑢.脂代谢及血清内脂素水平与绝经后骨质疏松症的 相关性研究[J].中医正骨,2012,24(04):16.
　CHEN Jun-jie*,LI Qing-qing,XIA Rong.*.Study on the correlations between the levels of lipid metabolism and serum visfatin and postmenopausal osteoporosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2012,24(09):16.

备注/Memo

备注/Memo:
基金项目:国家重点研发计划项目(2018YFC1704703); 中华中医药学会团体标准项目(20210704-BZ-CACM); 中央高校基本科研业务费专项——北京中医药大学新教师启动基金项目(2022-JYB-XJSJJ069)
通讯作者:陈卫衡 E-mail:drchenweiheng@bucm.edu.cn
更新日期/Last Update: 1900-01-01